Revolution Medicines, Inc. Warrant (RVMDW) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Revolution Medicines, Inc. Warrant Revenue Highlights


Latest Revenue (Y)

$11.58M

0

Revolution Medicines, Inc. Warrant Revenue by Period


Revolution Medicines, Inc. Warrant Revenue by Year

DateRevenueChange
2023-12-31$11.58M-67.27%
2022-12-31$35.38M20.38%
2021-12-31$29.39M-31.62%
2020-12-31$42.98M-

Revolution Medicines, Inc. Warrant generated $11.58M in revenue during NA 2023, up -67.27% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Revolution Medicines, Inc. Warrant Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$742.00K100.00%
2023-09-30--100.00%
2023-06-30$3.82M-45.48%
2023-03-31$7.01M100.00%
2022-12-31--

Revolution Medicines, Inc. Warrant generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

RVMDW Revenue FAQ


What is Revolution Medicines, Inc. Warrant’s yearly revenue?

Revolution Medicines, Inc. Warrant's yearly revenue for 2023 was $11.58M, representing a decrease of -67.27% compared to 2022. The company's yearly revenue for 2022 was $35.38M, representing an increase of 20.38% compared to 2021. RVMDW's yearly revenue for 2021 was $29.39M, representing a decrease of -31.62% compared to 2020.

What is Revolution Medicines, Inc. Warrant’s quarterly revenue?

Revolution Medicines, Inc. Warrant's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $742K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). RVMDW's quarterly revenue for Q3 2023 was $0, a -100.00% decrease from the previous quarter (Q2 2023).

What is Revolution Medicines, Inc. Warrant’s revenue growth rate?

Revolution Medicines, Inc. Warrant's revenue growth rate for the last 3 years (2021-2023) was -60.60%